Rabicoff Law | Resolving your IP disputes.
  • Firm
  • The Difference
  • Practices
  • Attorneys
  • News
  • Contact

Unwired Planet: Brakes applied to Patent Trial and Appeal Board

2/22/2017

 
Picture
The U.S. Court of Appeals for the Federal Circuit recently rejected the Patent Trial and Appeal Board’s understanding of what patents are eligible for “covered business method” review, suggesting that the appeal board had disregarded the standard set by statute.

Background

In 2013, three types of post-grant proceedings were created under the America Invents Act: post-grant review, inter partes review and covered business method review.

Post-grant review and inter partes review, while differing in the necessary requirements to bring a challenge, apply to all technological areas. Covered business method eligible patents are narrowly defined to include only those patents that teach financial transactions and services.

​View a reprint of the full Chicago Daily Law Bulletin article below.
Chicago Law Bulletin Article reprint
File Size: 93 kb
File Type: pdf
Download File

Intellectual Property Without Borders: How IP Protection for Low-Cost Medical Devices Improves Global Health

2/10/2017

 
Picture
Only two infectious diseases have been globally eradicated: smallpox and rinderpest. While both diseases caused people to suffer incredibly different symptoms, the diseases had one element in common. Patents protected the vaccines used to treat smallpox and rinderpest. Intellectual property protection has been crucial for several advances in the medical field, due to the high product development costs and chances of competitors copying the developing technologies. As of 2006, the cost of medical devices in the global marketplace exceeded $260 billion, and has only continued to rise.

However, because the production costs of these medical devices and pharmaceuticals are so high, millions of people around the world are unable to obtain necessary healthcare. For example, as of 2014, close to seventy percent of all cardiac pacemaker sales occurred in the United States and Europe, while several countries in Africa and Asia have absolutely no access to pacemakers. In order to respond to this problem, research scientists have begun developing low-cost medical technologies and using intellectual property rights to give people in developing countries access to adequate healthcare.

Continue to IPWatchdog Article

    Archives

    January 2018
    June 2017
    March 2017
    February 2017
    January 2017
    November 2016

    Categories

    All
    Rabicoff Law News

    RSS Feed

Location

Call

773.669.4590

directions

Connect

© 2024 Rabicoff Law LLC
These materials may be considered advertising for legal services. Prior results do not guarantee a similar outcome.
  • Firm
  • The Difference
  • Practices
  • Attorneys
  • News
  • Contact